Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Sass, Andrea ^a   Marchbank, Angela ^a   Tullis, Elizabeth ^b   LiPuma, John J ^c   Mahenthiralingam, Eshwar ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AMIKACIN; AZITHROMYCIN; AZTREONAM; CARRIER PROTEIN; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CHLORPROMAZINE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; GLUCOSE; IMIPENEM; ISOMERASE; LEVOFLOXACIN; MEROPENEM; MULTIDRUG EFFLUX SYSTEM PROTEIN; PHENYLACETIC ACID; PIPERACILLIN; PROCHLORPERAZINE; RIFAMPICIN; SQUALENE HOPENE CYCLASE; SULFAMETHOXAZOLE; TETRACYCLINE; THEOPHYLLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM MUTANT; BURKHOLDERIA CENOCEPACIA; EPIDEMIC; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; GENE MUTATION; GENE REPRESSION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; NONHUMAN; PHENOTYPE; UPREGULATION; CYSTIC FIBROSIS; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MICROBIOLOGY; MUTATION;

BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA CENOCEPACIA; CYSTIC FIBROSIS; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; GENE EXPRESSION PROFILING; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 79960557330     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-373     Document Type: Article

References (64)

1. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010, 23(2):299-323. 10.1128/CMR.00068-09, 2863368, 20375354.
2. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984, 104(2):206-210. 10.1016/S0022-3476(84)80993-2, 6420530.
3. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993, 342(8862):15-19. 10.1016/0140-6736(93)91881-L, 7686239.
4. Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 2005, 3(2):144-156. 10.1038/nrmicro1085, 15643431.
5. Mahenthiralingam E, Baldwin A, Dowson CG. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 2008, 104(6):1539-1551. 10.1111/j.1365-2672.2007.03706.x, 18217926.
6. Holden MTG, Seth-Smith HMB, Crossman LC, Sebaihia M, Bentley SD, Cerdeño-Tárraga AM, Thomson NR, Bason N, Quail MA, Shar S, et al. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 2009, 91(1):261-277.
7. Drevinek P, Mahenthiralingam E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infec 2010, 16(7):821-830.
8. Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1206-1212.
9. St Denis M, Ramotar K, Vandemheen K, Tullis E, Ferris W, Chan F, Lee C, Slinger R, Aaron SD. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis. Chest 2007, 131(4):1188-1196. 10.1378/chest.06-2611, 17426227.
10. Drevinek P, Holden MTG, Ge Z, Jones AM, Ketchell I, Gill RT, Mahenthiralingam E. Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infect Dis 2008, 8:121. 10.1186/1471-2334-8-121, 2559838, 18801206.
11. O'Grady EP, Viteri DF, Malott RJ, Sokol PA. Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia. BMC Genomics 2009, 10:441. 10.1186/1471-2164-10-441, 2753556, 19761612.
12. Buroni S, Pasca MR, Flannagan RS, Bazzini S, Milano A, Bertani I, Venturi V, Valvano MA, Riccardi G. Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol 2009, 9:200. 10.1186/1471-2180-9-200, 2753365, 19761586.
13. Rajyaguru JM, Muszynski MJ. Sensitization of Burkholderia cepacia to antibiotics by cationic drugs. J Antimicrob Chemother 1998, 41(2):277-280. 10.1093/jac/41.2.277, 9533472.
14. Chernish RN, Aaron SD. Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis. Curr Opin Pulm Med 2003, 9(6):509-515. 10.1097/00063198-200311000-00011, 14534404.
15. McIntyre K, Muller M, Ota J, Stephenson AL, Tullis E. Epidemic of Burkholderia cenocepacia ET12 in the Toronto Adult Cystic Fibrosis clinic: Lessons learned. Pediatric Pulmonology 2009,
16. Rodríguez-Rojas A, Mena A, Martín S, Borrell N, Oliver A, Blázquez J. Inactivation of the hmgA gene of Pseudomonas aeruginosa leads to pyomelanin hyperproduction, stress resistance and increased persistence in chronic lung infection. Microbiology 2009, 155(4):1050-1057. 10.1099/mic.0.024745-0, 19332807.
17. Levin BR, Rozen DE. Non-inherited antibiotic resistance. Nat Rev Microbiol 2006, 4(7):556-562. 10.1038/nrmicro1445, 16778840.
18. Mahenthiralingam E, Campbell ME, Speert DP. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. InfectImmun 1994, 62(2):596-605.
19. Barth AL, Pitt TL. Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbio 1995, 33(8):2192-2194.
20. Keith KE, Killip L, He P, Moran GR, Valvano MA. Burkholderia cenocepacia C5424 produces a pigment with antioxidant properties using a homogentisate intermediate. J Bacteriol 2007, 189(24):9057-9065. 10.1128/JB.00436-07, 2168628, 17933889.
21. Larsen GY, Stull TL, Burns JL. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol 1993, 31(4):788-792. 263564, 7681845.
22. Peeters E, Sass A, Mahenthiralingam E, Nelis H, Coenye T. Transcriptional response of Burkholderia cenocepacia J2315 sessile cells to treatments with high doses of hydrogen peroxide and sodium hypochlorite. BMC Genomics 2010, 11:90. 10.1186/1471-2164-11-90, 2830190, 20137066.
23. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: Activity and resistance. Antimicrobial Agents Chemother 1999, 43(4):727-737.
24. Menard A, de los Santos P, Graindorge A, Cournoyer B. Architecture of Burkholderia cepacia complex 70 σgene family: Evidence of alternative primary and clade-specific factors, and genomic instability. BMC Genomics 2007, 8:308. 10.1186/1471-2164-8-308, 2194791, 17784948.
25. Kazmierczak MJ, Wiedmann M, Boor KJ. Alternative sigma factors and their roles in bacterial virulence. Microbiol Mol Biol Reviews 2005, 69(4):527-543.
26. Kobayashi N, Nishino K, Yamaguchi A. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol 2001, 183(19):5639-5644. 10.1128/JB.183.19.5639-5644.2001, 95455, 11544226.
27. Trépanier S, Prince A, Huletsky A. Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. Antimicrobial Agents Chemother 1997, 41(11):2399-2405.
28. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial Agents Chemother 2001, 45(4):1151-1161.
29. Poirel L, Rodriguez-Martinez JM, Plésiat P, Nordmann P. Naturally occurring class a ß-lactamases from the Burkholderia cepacia complex. Antimicrobial Agents Chemother 2009, 53(3):876-882.
30. Kim JY, Jung HI, An YJ, Lee JH, Kim SJ, Jeong SH, Lee KJ, Suh PG, Lee HS, Lee SH, et al. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C β-lactamase. Mol Microbiol 2006, 60(4):907-916. 10.1111/j.1365-2958.2006.05146.x, 16677302.
31. Olivera ER, Minambres B, García B, Muñiz C, Moreno MA, Ferrández A, Díaz E, García JL, Luengo JM. Molecular characterization of the phenylacetic acid eatabolic pathway in Pseudomonas putida U: The phenylacetyl-CoA catabolon. Proc Natl Acad Sci USA 1998, 95(11):6419-6424. 10.1073/pnas.95.11.6419, 27761, 9600981.
32. Luengo JM, García JL, Olivera ER. The phenylacetyl-CoA catabolon: A complex catabolic unit with broad biotechnological applications. Mol Microbiol 2001, 39(6):1434-1442. 10.1046/j.1365-2958.2001.02344.x, 11260461.
33. Hamlin JN, Bloodworth RA, Cardona ST. Regulation of phenylacetic acid degradation genes of Burkholderia cenocepacia K56-2. BMC Microbiol 2009, 9:222. 10.1186/1471-2180-9-222, 2770484, 19835630.
34. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, Peters G. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006, 4(4):295-305. 10.1038/nrmicro1384, 16541137.
35. Chain PS, Denef VJ, Konstantinidis KT, Vergez LM, Agullo L, Reyes VL, Hauser L, Cordova M, Gomez L, Gonzalez M, et al. Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility. Proc Natl Acad Sci USA 2006, 103(42):15280-15287. 10.1073/pnas.0606924103, 1622818, 17030797.
36. Law RJ, Hamlin JNR, Sivro A, McCorrister SJ, Cardama GA, Cardona ST. A functional phenylacetic acid catabolic pathway is required for full pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans host model. J Bacteriol 2008, 190(21):7209-7218. 10.1128/JB.00481-08, 2580687, 18776009.
37. Huber B, Feldmann F, Köthe M, Vandamme P, Wopperer J, Riedel K, Eberl L. Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun 2004, 72(12):7220-7230. 10.1128/IAI.72.12.7220-7230.2004, 529107, 15557647.
38. Lewenza S, Conway B, Greenberg EP, Sokol PA. Quorum sensing in Burkholderia cepacia: Identification of the LuxRI homologs CepRI. J Bacteriol 1999, 181(3):748-756. 93439, 9922236.
39. Nair BM, Joachimiak LA, Chattopadhyay S, Montano I, Burns JL. Conservation of a novel protein associated with an antibiotic efflux operon in Burkholderia cenocepacia. FEMS Microbiol Letts 2005, 245(2):337-344.
40. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect 2004, 10(1):12-26. 10.1111/j.1469-0691.2004.00763.x, 14759229.
41. Fraud S, Campigotto AJ, Chen Z, Poole K. MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: Involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor. Antimicrobial Agents Chemother 2008, 52(12):4478-4482.
42. Kannenberg EL, Poralla K. Hopanoid biosynthesis and function in bacteria. Naturwissenschaften 1999, 86(4):168-176.
43. Feldman M, Bryan R, Rajan S, Scheffler L, Brunnert S, Tang H, Prince A. Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 1998, 66(1):43-51. 107856, 9423837.
44. Wolfgang MC, Jyot J, Goodman AL, Ramphal R, Lory S. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci USA 2004, 101(17):6664-6668. 10.1073/pnas.0307553101, 404102, 15084751.
45. Allikmets R, Gerrard B, Court D, Dean M. Cloning and organization of the abc and mdl genes of Escherichia coli: relationship to eukaryotic multidrug resistance. Gene 1993, 136(1-2):231-236. 10.1016/0378-1119(93)90470-N, 7904973.
46. Hunt TA, Kooi C, Sokol PA, Valvano MA. Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 2004, 72(7):4010-4022. 10.1128/IAI.72.7.4010-4022.2004, 427415, 15213146.
47. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130(5):797-810. 10.1016/j.cell.2007.06.049, 17803904.
48. Drevinek P, Baldwin A, Lindenburg L, Joshi LT, Marchbank A, Vosahlikova S, Dowson CG, Mahenthiralingam E. Oxidative stress of Burkholderia cenocepacia induces insertion sequence-mediated genomic rearrangements that interfere with macrorestriction-based genotyping. J Clin Microbiol 2010, 48(1):34-40. 10.1128/JCM.01433-09, 2812269, 19889907.
49. Moore RA, Deshazer D, Reckseidler S, Weissman A, Woods DE. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrobial Agents Chemother 1999, 43(3):465-470.
50. Chan YY, Tan TMC, Ong YM, Chua KL. BpeAB-OprB, a Multidrug Efflux Pump in Burkholderia pseudomallei. Antimicrobial Agents Chemother 2004, 48(4):1128-1135.
51. Hareland WA, Crawford RL, Chapman PJ, Dagley S. Metabolic function and properties of 4-hydroxyphenylacetic acid 1-hydroxylase from Pseudomonas acidovorans. J Bacteriol 1975, 121(1):272-285. 285641, 234937.
52. Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MCJ, Govan JR, Speert DP, Lipuma JJ, Vandamme P, Dowson CG. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 2005, 43(9):4665-4673. 10.1128/JCM.43.9.4665-4673.2005, 1234123, 16145124.
53. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrobial Chemother 2001, 48(SUPPL 1):5-16.
54. MacGowan AP, Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J Antimicrobial Chemother 2001, 48(SUPPL 1):17-28.
55. Den Hollander JG, Mouton JW, Verbrugh HA. Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics. Antimicrobial Agents Chemothery 1998, 42(4):744-748.
56. Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clinical Microbiol 1996, 34(5):1129-1135.
57. Lefebre MD, Valvano MA. Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex isolates. Appl Environ Microbiol 2002, 68(12):5956-5964. 10.1128/AEM.68.12.5956-5964.2002, 134411, 12450816.
58. Flannagan RS, Linn T, Valvano MA. A system for the construction of targeted unmarked gene deletions in the genus Burkholderia. Environ Microbiol 2008, 10(6):1652-1660. 10.1111/j.1462-2920.2008.01576.x, 18341581.
59. Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proceedings/International Conference on Intelligent Systems for Molecular Biology; ISMB International Conference on Intelligent Systems for Molecular Biology 1994, 2:28-36.
60. Bailey TL, Gribskov M. Combining evidence using p-values: Application to sequence homology searches. Bioinformatics 1998, 14(1):48-54. 10.1093/bioinformatics/14.1.48, 9520501.
61. Bendtsen JD, Nielsen H, Von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340(4):783-795. 10.1016/j.jmb.2004.05.028, 15223320.
62. Gardy JL, Laird MR, Chen F, Rey S, Walsh CJ, Ester M, Brinkman FSL. PSORTb v.2.0: Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 2005, 21(5):617-623. 10.1093/bioinformatics/bti057, 15501914.
63. Altschul SF, Madden TL, SchÃ{currency sign}ffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Research 1997, 25(17):3389-3402. 10.1093/nar/25.17.3389, 146917, 9254694.
64. Winsor GL, Khaira B, Van Rossum T, Lo R, Whiteside MD, Brinkman FSL. The Burkholderia Genome Database: Facilitating flexible queries and comparative analyses. Bioinformatics 2008, 24(23):2803-2804. 10.1093/bioinformatics/btn524, 2639269, 18842600.